Role of ring substitution on the inhibition of nicotinamide adenine dinucleotide dependent oxidations by 2-methyl-3-ortho-tolyl-6-hydroxy-4-quinazolone.
D000818:Animals; D001921:Brain / Q000378:metabolism; D055598:Chemical Phenomena; D002621:Chemistry; D002951:Citrates / Q000378:metabolism; D002952:Citric Acid Cycle; D005650:Fumarates / Q000378:metabolism; D005971:Glutamates / Q000378:metabolism; D066298:In Vitro Techniques; D007656:Ketoglutaric Acids / Q000378:metabolism; D008293:Malates / Q000378:metabolism; D008297:Male; D009243:NAD / Q000378:metabolism*; D010084:Oxidation-Reduction; D010100:Oxygen; D011773:Pyruvates / Q000378:metabolism; D011799:Quinazolines / Q000494:pharmacology*; D051381:Rats; D012964:Sodium / Q000378:metabolism; D013386:Succinates / Q000378:metabolism
D002951:Citrates; D005650:Fumarates; D005971:Glutamates; D007656:Ketoglutaric Acids; D008293:Malates; D011773:Pyruvates; D011799:Quinazolines; D013386:Succinates; D009243:NAD; D012964:Sodium; D010100:Oxygen